Furthermore, following the experiments with dissociated human GBM specimens, the authors postulated that the CD144+/CD133+ double-positive population represents the endothelial progenitor cells (EPCs) that arise from the CD133+ population and can differentiate into an endothelial phenotype [15]. The gene discussed is CDH5; the disease is glioblastoma.